Hunan Jingfeng Pharmaceutical - Asset Resilience Ratio

Latest as of December 2018: 0.38%

Hunan Jingfeng Pharmaceutical (000908) has an Asset Resilience Ratio of 0.38% as of December 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥20.00 Million

≈ $2.93 Million USD Cash + Short-term Investments

Total Assets

CN¥5.23 Billion

≈ $764.89 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1998–2018)

This chart shows how Hunan Jingfeng Pharmaceutical's Asset Resilience Ratio has changed over time. Check 000908 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Hunan Jingfeng Pharmaceutical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Hunan Jingfeng Pharmaceutical stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥20.00 Million	0.38%
Total Liquid Assets	CN¥20.00 Million	0.38%

Asset Resilience Insights

Limited Liquidity: Hunan Jingfeng Pharmaceutical maintains only 0.38% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Hunan Jingfeng Pharmaceutical Industry Peers by Asset Resilience Ratio

Compare Hunan Jingfeng Pharmaceutical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	2.74%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.48%
AstraZeneca PLC NYSE:AZN	Drug Manufacturers - General	0.10%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	Drug Manufacturers - General	17.40%
Aurora Optoelectronics Co Ltd SHG:600666	Drug Manufacturers - General	5.89%
NanJing Pharmaceutical Co Ltd SHG:600713	Drug Manufacturers - General	0.85%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	7.83%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%

Annual Asset Resilience Ratio for Hunan Jingfeng Pharmaceutical (1998–2018)

The table below shows the annual Asset Resilience Ratio data for Hunan Jingfeng Pharmaceutical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2018-12-31	0.38%	CN¥20.00 Million ≈ $2.93 Million	CN¥5.23 Billion ≈ $764.89 Million	+0.15pp
2016-12-31	0.23%	CN¥11.94 Million ≈ $1.75 Million	CN¥5.13 Billion ≈ $751.27 Million	+0.21pp
2015-12-31	0.02%	CN¥706.00K ≈ $103.31K	CN¥3.44 Billion ≈ $503.77 Million	-0.29pp
2009-12-31	0.31%	CN¥2.40 Million ≈ $351.20K	CN¥784.81 Million ≈ $114.84 Million	+0.21pp
2007-12-31	0.10%	CN¥801.34K ≈ $117.26K	CN¥814.38 Million ≈ $119.17 Million	+0.06pp
2006-12-31	0.04%	CN¥350.00K ≈ $51.22K	CN¥822.47 Million ≈ $120.35 Million	-3.49pp
2005-12-31	3.53%	CN¥29.66 Million ≈ $4.34 Million	CN¥840.14 Million ≈ $122.94 Million	-2.63pp
2004-12-31	6.16%	CN¥54.81 Million ≈ $8.02 Million	CN¥889.56 Million ≈ $130.17 Million	-10.65pp
2003-12-31	16.81%	CN¥165.26 Million ≈ $24.18 Million	CN¥983.02 Million ≈ $143.85 Million	+16.63pp
2002-12-31	0.18%	CN¥1.57 Million ≈ $229.79K	CN¥866.67 Million ≈ $126.82 Million	-8.42pp
2000-12-31	8.60%	CN¥60.00 Million ≈ $8.78 Million	CN¥697.92 Million ≈ $102.13 Million	-0.07pp
1999-12-31	8.67%	CN¥60.00 Million ≈ $8.78 Million	CN¥691.94 Million ≈ $101.25 Million	-1.90pp
1998-12-31	10.57%	CN¥50.00 Million ≈ $7.32 Million	CN¥473.15 Million ≈ $69.24 Million	--

pp = percentage points

About Hunan Jingfeng Pharmaceutical

SHE:000908 China Drug Manufacturers - General

Market Cap

$775.01 Million

CN¥5.30 Billion CNY

Market Cap Rank

#9918 Global

#2548 in China

Share Price

CN¥6.02

Change (1 day)

+0.67%

52-Week Range

CN¥4.58 - CN¥9.23

All Time High

CN¥16.99